The study analyses the role of this protein in tumour development and protection, and describes how its elimination leads to tumour cell death and activation of the immune System.

Specifically blocking this protein may be a useful strategy for treating a large number of patients with pancreatic cancer and could even be applicable to other types of tumours.

To achieve this, molecular modelling and artificial intelligence techniques were used, revealing for the first time a new structural model that describes a previously unknown cell-signalling mechanism.

The research opens the door to designing drugs that act on the interaction between the two proteins, thereby improving current cancer treatments.

The human brain generates memories from the representation of the stimuli it receives, endowing them with meaning. This is a mechanism of abstraction that does not merely store information.

Published scientific evidence indicates that this mechanism is not found in other animal species, suggesting that it is a key element in the construction of our intelligence.

The study characterizes, for the first time, the cells that produce these antibodies and identifies their point of origin in the tonsils.

These results open the door to the possibility of developing drugs and vaccines focused on this type of antibody, both for the treatment of allergies and other diseases linked to inflammation.

The study, led by the Hospital del Mar Research Institute and IRB Barcelona, shows that the determination of this protein, CTHRC1, can be used to assess patient prognosis. At the same time, it opens up new avenues to approach this type of tumour.

The research team has demonstrated that this biomarker can be detected using routine diagnostic tests in the clinical practice of any Pathology service.

The study, published in Medicine & Science in Sports & Exercise, identifies a causal relationship between a greater genetic predisposition for adequate cardiorespiratory capacity and a lower risk of developing these conditions.

The results suggest that increasing aerobic activity may provide protection against various cardiovascular, inflammatory, and other diseases.

The findings, published in Nature Communications, open the door to new prognostic markers and potential therapeutic strategies.

Targeting tumor cell adhesion impairs their ability to migrate and form metastases. The study was conducted using a preclinical mouse model.

However, it also finds that, in the experiences evaluated, the measure may increase the unequal distribution of roles between women and men. It notes that women devote more time to caregiving and domestic work, while men spend more on leisure.

The researchers conducted a systematic review of the scientific evidence surrounding this type of measure. They highlight that any initiative in this field must also include an analysis of other working conditions that may have an impact on health.

The most frequent cancers in Europe are breast, prostate, colorectal, and lung cancer. The highest survival rates a re seen in breast and prostate cancer, while pancreatic cancer has the poorest prognosis.

Databases from Spain, Estonia, and Switzerland show the best survival rates.